The impact of pricing and patent expiration on demand for pharmaceuticals: an examination of the use of broad-spectrum antimicrobials
Author:
- 4 September 2012
- journal article
- research article
- Published by Cambridge University Press (CUP) in Health Economics, Policy and Law
- Vol. 8 (1) , 7-20
Abstract
The aim of the analysis was to determine whether demand in Germany for specific antimicrobial agents is driven by prices that drop considerably when generic substitutes become available. A time-series approach was therefore carried out to explore price elasticities of demand for two different classes of broad-spectrum antimicrobials (fluoroquinolones and cephalosporins) using data on ambulatory antibiotics prescribed on the German statutory health insurance scheme and data on in-hospital antibiotic use in a German teaching hospital. In short, we attempted to explain demand for different antibiotics based on changes in price and hospital-wide morbidity. The data indicate that patent expiration is followed by substantial decreases in the price of antibiotics. In the outpatient sector, all antibiotics included in the analysis showed significant negative own-price elasticities of demand. However, in the hospital settings, significant own-price elasticities were only determined for some antibiotics, although price decreases were stronger than in the outpatient sector. We conclude that price dependence of demand for antimicrobials is present both in the ambulatory and the hospital setting. However, this is especially surprising in the hospital setting because price differences among the antibiotics observed are particularly small compared with the overall cost of hospitalisation.Keywords
All Related Versions
This publication has 26 references indexed in Scilit:
- Access and choice – competition under the roof of solidarity in German health care: an analysis of health policy reforms since 2004Health Economics, Policy and Law, 2010
- Quasiexperimental Study of the Effects of Antibiotic Use, Gastric Acid-Suppressive Agents, and Infection Control Practices on the Incidence of Clostridium difficile -Associated Diarrhea in Hospitalized PatientsAntimicrobial Agents and Chemotherapy, 2009
- Small area variations and welfare loss in the use of outpatient antibioticsHealth Economics, Policy and Law, 2008
- Epidemiology and Economic Impact??of Meticillin-Resistant Staphylococcus aureusPharmacoEconomics, 2007
- Socioeconomic determinants of regional differences in outpatient antibiotic consumption: Evidence from SwitzerlandHealth Policy, 2006
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database studyThe Lancet, 2005
- Antibiotikaanwendung in Deutschland im europäischen VergleichDMW - Deutsche Medizinische Wochenschrift, 2004
- Physician UtilizationMedical Care, 2002
- Demand systems and the true subindex of the cost of living for pharmaceuticalsApplied Economics, 1997
- PRACTITIONERS’ CORNER: Computing Robust Standard Errors for Within‐groups Estimators*Oxford Bulletin of Economics and Statistics, 1987